Comparison between glypican-3 and alpha-fetoprotein in discrimination of hepatocellular carcinoma from cirrhotic patients

Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

Alpha-L-Fucosidase Versus Alpha-Fetoprotein: A Comparative Study for Diagnosing Hepatocellular Carcinoma in Post-Viral Cirrhotic Patients

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma

Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels

Serum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis

Assessment of Alpha-1-Acid Glycoprotein as a new Biomarker for Hepatocellular Carcinoma

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma